Life Quality Study for PFAPA Patient

Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis

NCT02910258 ·Status: COMPLETED

A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen

NCT04845958 ·Status: COMPLETED

Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation

NCT02175589 ·Status: UNKNOWN ·Phase: PHASE2

MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN

NCT05495893 ·Status: UNKNOWN ·Phase: PHASE4

Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial

NCT01240850 ·Status: UNKNOWN ·Phase: PHASE3

Mobile App-Based Infection Monitoring in Familial Mediterranean Fever

NCT07212764 ·Status: ENROLLING_BY_INVITATION

Clusterin, Ptx3 and Pediatric Febrile Neutropenia (CluPPFeN)

NCT05584930 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine

NCT05092776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides

NCT00751517 ·Status: UNKNOWN ·Phase: PHASE2

Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome

NCT03540810 ·Status: UNKNOWN ·Phase: PHASE3

Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology

NCT02862054 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis

NCT04891640 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission

NCT00323440 ·Status: WITHDRAWN

FMF and Atheroscelerosis

NCT06047938 ·Status: NOT_YET_RECRUITING

Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)

NCT02243228 ·Status: UNKNOWN ·Phase: PHASE2

Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy

NCT06336733 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis

NCT03920722 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA

NCT04944524 ·Status: UNKNOWN ·Phase: PHASE4

Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease

NCT04120168 ·Status: COMPLETED

Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever

NCT05190991 ·Status: RECRUITING ·Phase: PHASE2

Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis

NCT00414128 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis

NCT00059748 ·Status: RECRUITING

Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome

NCT00577525 ·Status: COMPLETED

Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis

NCT05428826 ·Status: RECRUITING ·Phase: PHASE4

Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis

NCT05101447 ·Status: WITHDRAWN ·Phase: PHASE2